DF
IRMD icon

DecisionPoint Financial’s iRadimed IRMD Stock Holding History

DecisionPoint Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$867 Hold
9
– – ﹤0.01% 379
2025
Q4 		$876 Hold
9
– – ﹤0.01% 426
2025
Q3 		$634 Hold
9
– – ﹤0.01% 411
2025
Q2 		$545 Buy
+9
New +$493 ﹤0.01% 426

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DecisionPoint Financial's IRMD Position: Q1 2026 in Review

DecisionPoint Financial held its iRadimed (IRMD) position steady in Q1 2026 at 9 shares worth $867. The position accounts for ﹤0.01% of the portfolio, ranked #379.

DecisionPoint Financial first reported a position in IRMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $876 in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • DecisionPoint Financial held 9 shares of iRadimed worth $867 as of Q1 2026.
  • DecisionPoint Financial left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of DecisionPoint Financial's portfolio in Q1 2026, its #379 holding.
  • DecisionPoint Financial first reported a position in iRadimed in Q2 2025 and has held it in 4 quarters since.
  • DecisionPoint Financial's iRadimed position peaked at $876 in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.